Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE We measured the frequency of a novel mutation (Gly2019 ser) in familial Parkinson's disease by screening genomic DNA of patients and controls. 15680455

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE We amplified and sequenced the coding region of LRRK2 from genomic DNA by PCR, and identified a heterozygous mutation (Gly2019 ser) present in four of 61 (6.6%) unrelated families with Parkinson's disease and autosomal dominant inheritance. 15680456

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE We investigated the frequency of a common heterozygous mutation, 2877510 g-->A, which produces a glycine to serine aminoacid substitution at codon 2019 (Gly2019 ser), in idiopathic Parkinson's disease. 15680457

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Subsequently, 42 family members of the 13 probands were examined; 22 have an LRRK2 G2019S substitution, 7 with a diagnosis of PD. 15726496

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE The G2019S LRRK2 mutation is uncommon in an Asian cohort of Parkinson's disease patients. 15955629

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE The most common mutation, a heterozygous 6055 G>A transition (G 2019 S) accounts for approximately 3--10% of familial Parkinson's disease and 1--8% sporadic Parkinson's disease in several European-derived populations. 16102903

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE The influence of the G2019S substitution on protein function and disease phenotype has yet to be fully resolved, but its elucidation will undoubtedly further our understanding of the mechanisms underlying Parkinson's disease. 16102999

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. 16149095

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Referral-based studies indicate that a mutation (G2019S) in exon 41 of the LRRK2 gene might be a common cause of Parkinson disease (PD). 16157909

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE G2019S LRRK2 mutation in French and North African families with Parkinson's disease. 16240353

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE The G2019S mutation in the LRRK2 gene is reportedly a common cause of familial Parkinson's disease (PD) and may also have a significant role in nonfamilial PD. 16250030

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE G2019S is the most common genetic determinant of Parkinson's disease identified so far. 16272257

2005

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Herein, we report that the most common neuropathology of G2019S-associated Parkinson's disease is Lewy body disease. 16437559

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE This gene, LRRK2, contains mutations that cause an autosomal dominant PD, including a mutation, G2019S, which is the most common PD causing mutation identified to date. 16467219

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Prevalence of the LRRK2 G2019S mutation in a UK community based idiopathic Parkinson's disease cohort. 16614029

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. 16622859

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE One specific LRRK2 mutation, G2019S, was reported in 18% of people with PD of Ashkenazi descent, supporting a founder effect in this population. 16632201

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Herein we have assessed the frequency of G2019S in a referral-based series of 225 patients with Parkinson's disease (PD) from the region of Asturias, Northern Spain. 16643318

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE We conclude that in these patients carrying the LRRK2 Gly2019Ser mutation, the neurodegenerative process results in a pattern of nigrostriatal dopaminergic dysfunction similar to that observed in IPD. 16671078

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. 16728648

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. 16750929

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE Alteration G2019S in the leucine-rich repeat kinase 2 gene (LRRK2) has been identified in several populations of patients with parkinsonism, including Ashkenazi Jewish subjects with Parkinson disease. 16781064

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE We conclude that the LRRK2 G2019S mutation constitutes a significant factor for PD in the Swedish population and that it is not completely penetrant. 16817197

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE G2019S, located at a kinase (MAPKKK) domain, is the most common mutation in the LRRK2 gene in PD, Two adjacent mutations (I2012T and I2020T) were mapped to the same domain suggesting shared pathogenic mechanism of these mutations. 16939701

2006

dbSNP: rs34637584
rs34637584
CUI: C0030567
Disease: Parkinson Disease
Parkinson Disease
0.900 GeneticVariation BEFREE LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. 16960813

2006